Politics & Policy

One of the outstanding issues for the California Institute for Regenerative Medicine, which is charged with investing the $3 billion allocated by California voters for stem cell research under Proposition 71, has been how to provide incentives for companies to license IP generated under the

Read the full 457 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE